Bosutinib, a Lyn/Btk inhibiting tyrosine kinase inhibitor, is ineffective in advanced systemic mastocytosis

Nicole Randall; Elizabeth L. Courville; Linda Baughn; Lawrence Afrin; Celalettin Ustun

doi:10.1002/ajh.23942

Bosutinib, a Lyn/Btk inhibiting tyrosine kinase inhibitor, is ineffective in advanced systemic mastocytosis

Nicole Randall
, Elizabeth L. Courville
, Linda Baughn
, Lawrence Afrin
, Celalettin Ustun

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	E74-E74
Journal	American Journal of Hematology
Volume	90
Issue number	4
DOIs	https://doi.org/10.1002/ajh.23942
State	Published - Apr 1 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1002/ajh.23942

Find It

Find It at U of M Libraries

Cite this

@article{7be350fa83fa43599d9d2a33cc0a1de2,

title = "Bosutinib, a Lyn/Btk inhibiting tyrosine kinase inhibitor, is ineffective in advanced systemic mastocytosis",

author = "Nicole Randall and Courville, \{Elizabeth L.\} and Linda Baughn and Lawrence Afrin and Celalettin Ustun",

year = "2015",

month = apr,

day = "1",

doi = "10.1002/ajh.23942",

language = "English (US)",

volume = "90",

pages = "E74--E74",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Bosutinib, a Lyn/Btk inhibiting tyrosine kinase inhibitor, is ineffective in advanced systemic mastocytosis

AU - Randall, Nicole

AU - Courville, Elizabeth L.

AU - Baughn, Linda

AU - Afrin, Lawrence

AU - Ustun, Celalettin

PY - 2015/4/1

Y1 - 2015/4/1

UR - https://www.scopus.com/pages/publications/84925354373

UR - https://www.scopus.com/pages/publications/84925354373#tab=citedBy

U2 - 10.1002/ajh.23942

DO - 10.1002/ajh.23942

M3 - Article

C2 - 25641616

AN - SCOPUS:84925354373

SN - 0361-8609

VL - 90

SP - E74-E74

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 4

ER -

Bosutinib, a Lyn/Btk inhibiting tyrosine kinase inhibitor, is ineffective in advanced systemic mastocytosis

UN SDGs

Publisher link

Find It

Other files and links

Cite this